These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2445366)

  • 1. Variations in the relative activities of erythrocyte membrane ATPase with changes in severity of sickle cell anemia.
    Eluwa EO; Obidoa O; Obi GO; Onwubiko HA
    Biochem Med Metab Biol; 1987 Oct; 38(2):142-8. PubMed ID: 2445366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane enzymes in sickle cell anemia. 2. Acetylcholinesterase and ATPase activities.
    Eluwa EO; Obidoa O; Ogan AU; Onwubiko HA
    Biochem Med Metab Biol; 1990 Dec; 44(3):234-7. PubMed ID: 2149641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Ca++, Mg++, and Na+ + K+ ATPase activities in erythrocytes of sickle cell anemia.
    Luthra MG; Sears DA
    Blood; 1982 Dec; 60(6):1332-6. PubMed ID: 6291675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Ca2++Mg2+)-ATPase activity of sickle cell membranes: decreased activation by red blood cell cytoplasmic activator.
    Gopinath RM; Vincenzi FF
    Am J Hematol; 1979; 7(4):303-12. PubMed ID: 161856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between (Ca2+ + Mg2+)-ATPase and the soluble activator (calmodulin) in erythrocytes containing haemoglobin S.
    Dixon E; Winslow RM
    Br J Haematol; 1981 Mar; 47(3):391-7. PubMed ID: 6109544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ca2+-pump of sickle cell plasma membranes. Purification and reconstitution of the ATPase enzyme.
    Niggli V; Adunyah ES; Cameron BF; Bababunmi EA; Carafoli E
    Cell Calcium; 1982 May; 3(2):131-51. PubMed ID: 6126277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calmodulin-stimulated (Ca2+ + Mg2+)-ATPase in hemoglobin S erythrocyte membranes: effects of sickling and oxidative agents.
    Leclerc L; Girard F; Galacteros F; Poyart C
    Biochim Biophys Acta; 1987 Feb; 897(1):33-40. PubMed ID: 2948569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
    J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human red blood cell membrane adenylate cyclase in sickle-cell disease.
    Delaunay J; Piau JP; Girot R; Fischer S; Tortolero M; Schapira G
    Isr J Med Sci; 1978 Nov; 14(11):1170-2. PubMed ID: 750545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell anemia induces changes in peripheral lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in patients under treatment.
    Castilhos LG; Doleski PH; Bertoldo TM; Passos DF; Bertoncheli Cde M; Rezer JF; Schlemmer JB; Leal DB
    Biomed Pharmacother; 2015 Jul; 73():102-8. PubMed ID: 26211589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease].
    Lu G; Ouyang S; Pei Z
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):68-70. PubMed ID: 11938746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phosphoinositide kinases in normal and sickle anaemia red cells.
    Rhoda-Hardy-Dessources MD; de Neef RS; Mérault G; Giraud F
    Biochim Biophys Acta; 1993 Mar; 1181(1):90-6. PubMed ID: 8384492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte membrane Ca2+ ATPase: reactivities of human A, AS, and S erythrocytes with steroid hormones.
    Olawoye TO
    Biochem Med Metab Biol; 1989 Dec; 42(3):179-84. PubMed ID: 2532023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics.
    Rahmani-Jourdheuil D; Mourayre Y; Vague P; Boyer J; Juhan-Vague I
    Diabetes; 1987 Sep; 36(9):991-5. PubMed ID: 3038641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative computerized image analysis of fetal hemoglobin distribution patterns in sickle cell anemia and its variants.
    Miale TD; Lawson DL; Rotolo LS; Rotolo FS
    Hemoglobin; 1978; 2(4):291-314. PubMed ID: 701087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of erythrocyte membrane ATPases with antisickling and anaesthetic substances and ionophoric antibiotics.
    Abu-Salah KM
    Life Sci; 1996; 58(3):187-93. PubMed ID: 9499159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of red cell deformability and hydration reflect HbF and HbA
    Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
    Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.